Results 21 to 30 of about 412,112 (380)
Frontiers in Pharmacology, 2021 Abnormal proliferation of pulmonary artery smooth muscle cells (PASMCs) is a critical pathological feature in the pathogenesis of pulmonary arterial hypertension (PAH), but the regulatory mechanisms remain largely unknown.
Yong-Jie Chen +14 more
doaj +1 more source
Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients [PDF]
, 1995 Background.: We and others have demonstrated that a low level of donor cell chimerism was present for years after transplantation in tissues and peripheral blood of heart and lung recipients; it was associated, in the latter, with a lower incidence of ...
Abdul S. Rao +34 more
core +1 more source
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy [PDF]
, 1984 Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts ...
Atchison, RW +12 more
core +1 more source
Extracorporeal support for pulmonary resection: current indications and results. [PDF]
, 2016 Extracorporeal assistances are exponentially used for patients, with acute severe but reversible heart or lung failure, to provide more prolonged support to bridge patients to heart and/or lung transplantation.
Gonzalez, M. +5 more
core +2 more sources
Heart or heart-lung transplantation for patients with congenital heart disease in England
Heart, 2019 Background Increased longevity in patients with congenital heart disease (CHD) is associated with late complications, mainly heart failure, which may not be amenable to redo surgery and become refractory to medical therapy and so, trigger referral for ...
K. Dimopoulos +9 more
semanticscholar +1 more source
Chest, 1988 The survival rate (average, 50%) of patients undergoing cardiopulmonary transplantation falls well below that expected for cardiac transplantation alone. We give a broad overview of the various grounds upon which this difference is likely based and discuss recent advances in each area: 1) criteria for the selection of candidates and donors, 2) methods ...
+11 more sources
Haematologica, 2013 Delayed immune recovery is a characteristic feature of allogeneic hematopoietic stem cell transplantation in adult recipients. Although recipient thymic T-cell neogenesis contributes to T-cell regeneration after transplantation, thymic recovery in the ...
Zachariah McIver +8 more
doaj +1 more source
Severe Emphysema Treated with Bilateral Lung Sealant: A Case Series with Long-Term Follow-Up
Biomedicine Hub, 2023 Bronchoscopic lung volume reduction (BLVR) for emphysematous hyperinflation has evolved during the last two decades as an alternative to lung volume reduction surgery (LVRS) with lower morbidity and mortality.
Cecilia Lindnér +5 more
doaj +1 more source
Infections in Heart, Lung, and Heart-Lung Transplantation [PDF]
, 2019 Half a century has passed since the first orthotopic heart transplant took place. Surgical innovations allowed for heart, lung, and heart-lung transplantation to save lives of patients with incurable chronic cardiopulmonary conditions. The complexity of the surgical interventions, chronic host health conditions, and antirejection immunosuppressive ...
Andrés F. Henao-Martínez +1 more
openaire +2 more sources
Outcome after heart–lung or lung transplantation in patients with Eisenmenger syndrome
Heart, 2019 Objective The optimal timing for transplantation is unclear in patients with Eisenmenger syndrome (ES). We investigated post-transplantation survival and transplantation-specific morbidity after heart–lung transplantation (HLTx) or lung transplantation ...
Cristel S. Hjortshøj +9 more
semanticscholar +1 more source